Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular
In this work, we investigated the quantitative relationship between biological activity against non-small cell lung cancer (NSCLC) and the molecular structure of a series of 38 cyclohexane-1,3-dione-dimidone derivatives. For this purpose, molecular descriptors calculated by DFT-B3LYP/6-31G, topologi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medical Sciences Forum |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9992/14/1/106 |
_version_ | 1797609770587258880 |
---|---|
author | Khaoula Mkhayar Ossama Daoui Rachid Haloui Souad Elkhattabi Samir Chtita |
author_facet | Khaoula Mkhayar Ossama Daoui Rachid Haloui Souad Elkhattabi Samir Chtita |
author_sort | Khaoula Mkhayar |
collection | DOAJ |
description | In this work, we investigated the quantitative relationship between biological activity against non-small cell lung cancer (NSCLC) and the molecular structure of a series of 38 cyclohexane-1,3-dione-dimidone derivatives. For this purpose, molecular descriptors calculated by DFT-B3LYP/6-31G, topological, and physicochemical analysis were used. The results of the evaluations of the quantitative activity structure relationship (QSAR) models developed in this work via Multiple Linear Regression and via Multiple Non-Linear Regression (MLR and MNLR) techniques indicate the high predictive power of these models, (R<sup>2</sup> = 0.913; R<sup>2</sup><sub>CV</sub> = 0.85, R<sup>2</sup><sub>test</sub> = 0.934) for the linear model and (R<sup>2</sup> = 0.991; R<sup>2</sup><sub>CV</sub> = 0.82; R<sup>2</sup><sub>test</sub> = 0.997) for the nonlinear model. Using predictions from the QSAR model, new molecular structures were designed, their activity against NSCLC was evaluated, and the most important interactions between these molecules and the human c-Met protein were predicted. The predictions from QSAR models, molecular docking, and an evaluation of the in silico ADMET properties suggested that 1 of the 16 newly designed molecules is a candidate that may be a drug for NSCLC. |
first_indexed | 2024-03-11T06:06:02Z |
format | Article |
id | doaj.art-4b7e3677b70045d3b734460cb955c56c |
institution | Directory Open Access Journal |
issn | 2673-9992 |
language | English |
last_indexed | 2024-03-11T06:06:02Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Medical Sciences Forum |
spelling | doaj.art-4b7e3677b70045d3b734460cb955c56c2023-11-17T12:58:16ZengMDPI AGMedical Sciences Forum2673-99922022-11-0114110610.3390/ECMC2022-13245Design of New Derivatives of Dimedone Molecules Using QSAR and Docking MolecularKhaoula Mkhayar0Ossama Daoui1Rachid Haloui2Souad Elkhattabi3Samir Chtita4Laboratory of Engineering, Systems and Applications, National School of Applied Sciences, Sidi Mohamed Ben Abdellah-Fez University, Fez B.P 30000, MoroccoLaboratory of Engineering, Systems and Applications, National School of Applied Sciences, Sidi Mohamed Ben Abdellah-Fez University, Fez B.P 30000, MoroccoLaboratory of Engineering, Systems and Applications, National School of Applied Sciences, Sidi Mohamed Ben Abdellah-Fez University, Fez B.P 30000, MoroccoLaboratory of Engineering, Systems and Applications, National School of Applied Sciences, Sidi Mohamed Ben Abdellah-Fez University, Fez B.P 30000, MoroccoLaboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M’Sik, Hassan II University of Casablanca, Casablanca B.P 7955, MoroccoIn this work, we investigated the quantitative relationship between biological activity against non-small cell lung cancer (NSCLC) and the molecular structure of a series of 38 cyclohexane-1,3-dione-dimidone derivatives. For this purpose, molecular descriptors calculated by DFT-B3LYP/6-31G, topological, and physicochemical analysis were used. The results of the evaluations of the quantitative activity structure relationship (QSAR) models developed in this work via Multiple Linear Regression and via Multiple Non-Linear Regression (MLR and MNLR) techniques indicate the high predictive power of these models, (R<sup>2</sup> = 0.913; R<sup>2</sup><sub>CV</sub> = 0.85, R<sup>2</sup><sub>test</sub> = 0.934) for the linear model and (R<sup>2</sup> = 0.991; R<sup>2</sup><sub>CV</sub> = 0.82; R<sup>2</sup><sub>test</sub> = 0.997) for the nonlinear model. Using predictions from the QSAR model, new molecular structures were designed, their activity against NSCLC was evaluated, and the most important interactions between these molecules and the human c-Met protein were predicted. The predictions from QSAR models, molecular docking, and an evaluation of the in silico ADMET properties suggested that 1 of the 16 newly designed molecules is a candidate that may be a drug for NSCLC.https://www.mdpi.com/2673-9992/14/1/106QSARADMETmolecular dockingNSCLCC-met |
spellingShingle | Khaoula Mkhayar Ossama Daoui Rachid Haloui Souad Elkhattabi Samir Chtita Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular Medical Sciences Forum QSAR ADMET molecular docking NSCLC C-met |
title | Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular |
title_full | Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular |
title_fullStr | Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular |
title_full_unstemmed | Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular |
title_short | Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular |
title_sort | design of new derivatives of dimedone molecules using qsar and docking molecular |
topic | QSAR ADMET molecular docking NSCLC C-met |
url | https://www.mdpi.com/2673-9992/14/1/106 |
work_keys_str_mv | AT khaoulamkhayar designofnewderivativesofdimedonemoleculesusingqsaranddockingmolecular AT ossamadaoui designofnewderivativesofdimedonemoleculesusingqsaranddockingmolecular AT rachidhaloui designofnewderivativesofdimedonemoleculesusingqsaranddockingmolecular AT souadelkhattabi designofnewderivativesofdimedonemoleculesusingqsaranddockingmolecular AT samirchtita designofnewderivativesofdimedonemoleculesusingqsaranddockingmolecular |